Pharmacologic interventions for primary glenohumeral osteoarthritis.
| Autor: | Velasquez Garcia, Ausberto, Ingala Martini, Liborio, Franco Abache, Andres |
|---|---|
| Předmět: |
THERAPEUTIC use of narcotics
THERAPEUTIC use of hyaluronic acid MENTAL depression risk factors GLENOHUMERAL joint PHARMACOLOGY MEDICAL protocols SHOULDER pain BURSITIS RADIOGRAPHY PAIN measurement PHYSICAL therapy NONSTEROIDAL anti-inflammatory agents ADRENOCORTICAL hormones COMPUTED tomography DRUG therapy TENDINITIS ANXIETY MAGNETIC resonance imaging FUNCTIONAL status CYCLOOXYGENASE 2 PLATELET-rich plasma MUSCLE weakness DICLOFENAC INTRA-articular injections OSTEOARTHRITIS QUALITY of life PYRIDINE EARLY diagnosis BONE marrow transplantation BICEPS brachii DISEASE progression RANGE of motion of joints ACETAMINOPHEN |
| Zdroj: | JAAPA: Journal of the American Academy of Physician Assistants (Lippincott Williams & Wilkins); Jul2024, Vol. 37 Issue 7, p52-59, 8p |
| Abstrakt: | Primary glenohumeral osteoarthritis is a multifactorial condition with a complex cause that affects patients across different age groups, impairing physiologic and psychologic well-being, and substantially reducing patient quality of life and overall productivity. To effectively manage this condition, healthcare providers need to be well informed about treatment guidelines, as well as the available therapeutic options and the evidence supporting their use. Nonsurgical interventions should be regarded as the primary treatment option, particularly for patients in the initial phases of this condition. No conclusive guidelines exist for treating young and active patients, and the literature lacks high-quality data to evaluate the efficacy, safety, and long-term consequences of several interventions, regardless of patient characteristics and expectations. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|